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Abstract
Background: Conjugated linoleic acid (CLA) is a group of polyunsaturated fatty acids which have
been extensively studied in the past two decades. However, conjugated octadecatrienoic acid such
as  cis-9,trans-11,cis-15 and cis-9,trans-13,cis-15, recently identified, have not been extensively
investigated. This work presents bioavailability and tissue incorporation of a mixture of conjugated
octadecatrienoic (CLnA) acids ingested as free fatty acids (FFA) and triacylglycerols (TAG).
Results: Male Wistar rats were fed rumenic acid (RA: cis-9,trans-11 18:2) and a CLnA mixture (cis-
9,trans-11,cis-15 18:3 and cis-9,trans-13,cis-15 18:3) as FFA and TAG for 8 days. RA and CLnA were
both totally absorbed when given as FFA as well as TAG. Both isomers of CLnA as FFA or TAG
were incorporated into neutral lipids. Metabolites up to 22:6 conjugated isomers were present in
liver and plasma phospholipids of rats fed the CLnA diets.
Conclusion: Finally, CLnA are as well absorbed as RA in vivo and their incorporation into tissues
and bioconversion are similar when ingested as FFA or as TAG.
Background
Conjugated linoleic acid (CLA) is a group of polyunsatu-
rated fatty acids (PUFA) found in ruminant meat (about
0.4% of the total lipids) and milk products (about 1% of
the total lipids) with a conjugated double bonds system
[1]. Among the CLA family, rumenic acid (RA), cis-9,trans-
11 18:2 is the major conjugated isomer found in rumi-
nant fat. Many health benefits have been attributed to RA
isomers like inhibition of carcinogenesis in rats [2]
whereas CLA mixtures have demonstrated abilities to
modulate atherosclerotic plaque formation in rabbits and
hamsters [3,4] and to decrease body fat mass in mice [5].
Although many investigations were done regarding pre-
vention of diseases, few studies have investigated the
impact of the ingested CLA form (FFA, TAG or FAME) on
tissue metabolism and absorption [6]. In this respect,
Fernie et al. [6] showed that CLA absorption in humans as
FFA and TAG is similar as illustrated by their occurrence
into chylomicrons, while the absorption was lower for
fatty acid methyl esters.
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Conjugated alpha linolenic acid (CLnA) is another group
of PUFA. One isomer has recently been reported in milk
fat at a level of about 0.03% of total fatty acids [7]. The cis-
9,trans-11,cis-15 18:3 isomer results from the biohydro-
genation of α-linolenic acid. The cis-9,trans-11,cis-15 18:3
isomer combines the conjugated double bond system of
RA and the n-3 double bond of α-linolenic acid (Figure 1)
which confers this fatty acid a high bioactive potential.
The metabolic fate of a synthetic mixture of FFA of two
conjugated α-linolenic acids containing equimolar con-
centrations of cis-9,trans-11,cis-15 18:3 and cis-9,trans-13,
cis-15 18:3 isomers has already been studied in rats [8]. In
that study CLnA isomers had been given intragastrically
after a two weeks lipid deprivation period in order to
enhance the bioconversion. [8]. Moreover, no investiga-
tions were done regarding the absorption efficiency.
The aim of the present study was to determine the absorp-
tion efficiency, incorporation and metabolism of a mix-
ture of conjugated α-linolenic acid in growing rats under
nutritional and physiological conditions.
Results
Animals
RA intake ranged from 330 ± 30 mg/day for the TAG
group to 338 ± 14 mg/day (means ± SD) for the FFA
group. CLnA intake ranged from 323 ± 25 mg/day for the
FFA group to 334 ± 20 mg/day for the TAG group. No sig-
Structure of both isomers included in the CLnA mixture compared to rumenic acid Figure 1
Structure of both isomers included in the CLnA mixture compared to rumenic acid.
Table 1: Fatty acid composition (%) of the lipid fraction of each diet
FFA TAG
Fatty acids RA CLnA RA CLnA
16:0 3 . 43 . 44 . 04 . 2
16:1 c-9 0 . 10 . 10 . 10 . 1
18:0 3 . 03 . 02 . 92 . 9
18:1 c-9 68.7 67.5 69.1 67.8
18:2 c-9,c-12 9.9 9.8 10.0 10.0
18:3 c-9,c-12,c-15 1 . 21 . 11 . 21 . 1
18:2 c-9,t-11 10.5 0.3 10.0 0.2
18:2 t-10,c-12 ND 0.5 ND 0.5
18:3 c-9,t-11,c-15 and c-
9,t-13,c-15
ND 11.1 ND 10.7
Others 3 . 23 . 72 . 73 . 0Nutrition & Metabolism 2006, 3:8 http://www.nutritionandmetabolism.com/content/3/1/8
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nificant differences on the total diet consumption were
observed among the four groups.
At the end of the feeding period, the weights of the ani-
mals were not significantly different, 227 ± 6 (means ±
SD); 221 ± 10 in groups fed RA and CLnAs as FFA and 218
± 7; 223 ± 6 in groups fed the RA and the CLnAs as TAG.
Effects of dietary fat on fatty acid digestibility and 
absorption
Table 2 shows the apparent digestibility efficiency for total
fatty acids and for each fatty acid. Digestibility of total
fatty acid was not significantly different between the four
experimental groups. Each group had a lower absorption
of saturated fatty acids compared to monounsaturated
and polyunsaturated fatty acids. RA and CLnA have been
totally absorbed as FFA and TAG suggesting that under
these conditions, there is no difference in absorption.
Effects of dietary fat on the fatty acid profile in liver, 
plasma and adipose tissue
The main fatty acids in liver, plasma and adipose are pre-
sented in Table 3. RA and CLnA accumulated preferen-
tially in neutral lipids. No major differences between RA
and CLnA accumulation were seen whatever the dietary
form, FFA or TAG. RA and CLnA accounted for up to 3%
of the total FAME of the adipose tissue. On the other
hand, slight differences were found in monounsaturated
fatty acids of the liver neutral lipids between rats fed the
FFA form of RA and CLnA. The rats fed the TAG form had
significant differences (P < 0.05) of saturated fatty acids
profile of plasma PL. The animals fed CLnA as FFA had
lower content of arachidonic acid in liver and plasma PL.
CLnA Metabolites
CLnA metabolites are shown in Table 4. The cis-9,trans-
11,cis-15 18:3 was elongated and desaturated up to cis-
4,cis-7,cis-10,cis-13,trans-15,cis-19 22:6 while the cis-
9,trans-13,cis-15 18:3 was metabolized up to cis-5,cis-8,cis-
11,trans-15,cis-17 20:5. Conjugated metabolites accumu-
lated in both neutral lipids and polar lipids. However, the
cis-7,cis-10,cis-13,trans-15,cis-19 22:5 and the cis-4,cis-
7,cis-10,cis-13,trans-15,cis-19 22:6 were exclusively
detected in liver and plasma phospholipids. No differ-
ences in the amount of the metabolites were found
between the two dietary forms given (FFA or TAG). This
suggests that there was no difference in the metabolic fate
(elongation and desaturation) of CLnA when ingested as
FFA and as TAG.
Discussion
Most of the studies so far published on CLA focussed on
their putative effects on biological function and preven-
tion of metabolic disorders. However, few studies consid-
ered the effect of the dietary form (FFA or TAG) on their
bioavailabilty and metabolism [6], while dietary supple-
ment are often available as free fatty acids. The major rea-
son may be that TAG are more expensive. On the other
hand, only one study has reported that force-fed conju-
gated α-linolenic acids (CLnA) given as FFA were incorpo-
rated into liver and adipose tissue of PUFA deprived rat
and reported that both CLnA isomers were following the
Table 2: Apparent digestion efficiency (%) of the dietary fatty acids in Wistar rats fed RA- or CLnA-supplemented diets as free fatty 
acids (FFA) or as triacyglycerols (TAG)
FFA TAG
RA CLnA RA CLnA
Mean SD Mean SD Mean SD Mean SD
Total fatty acids 98.0 0.3 98.2 0.2 98.2 0.2 98.0 0.3
Fatty acids
16:0 89.6 0.8 89.6 0.5 86.6a 1.1 90.0 0.8
18:0 83.1 2.0 85.8 2.0 80.2 1.7 80.4 2.4
18:1 c-9 98.6 0.3 99.2 0.2 99.2 0.2 98.9 0.3
18:2 c-9,c-12 99.4 1.0 99.3 0.1 99.5 < 0.1 99.4 0.08
18:3 c-9,c-12,c-15 1 0 0 . 0<  0 . 11 0 0 . 0<  0 . 11 0 0 . 0<  0 . 11 0 0 . 0<  0 . 1
18:2 c-9, t-11 99.9 < 0.1 100.0 < 0.1 99.9 < 0.1 100.0 < 0.1
18:2 t-10,c-12 ND < 0.1 100,0 < 0.1 ND ND 100.0 < 0.1
18:3 c-9,t-11,c-15 and 
c-9,t-13,c-15
ND < 0.1 100,0 < 0.1 ND ND 99.9 < 0.1
Values with different letters are significantly different (P < 0,05) and compare the fatty acid (RA and CLnA) under the same form (FFA or TAG)
Values with an * are significantly different (P < 0,05) and compare the form (FFA and TAG) within one diet (RA and CLnA).Nutrition & Metabolism 2006, 3:8 http://www.nutritionandmetabolism.com/content/3/1/8
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elongation/desaturation pathway [8]. Otherwise, no stud-
ies have shown their absorption efficiency in nutritional
conditions.
In the present study, the experimental fatty acids (RA and
CLnA mixture) were given as FFA or as randomized TAG
and were equally incorporated into tissues (Table 2). No
significant differences in absorption levels were found
between those two lipid forms. This suggests that the die-
tary form did not modify the incorporation of RA and of
CLnA into tissues under our experimental conditions.
These data are in agreement with the study of De Schrijver
et al. [10] who compared the absorption of fish oil fatty
acids given as FFA and TAG. While in the present study RA
and CLnA were totally absorbed, a previous study using
lymphatic recovery showed that a CLA mixture given as
FFA was less absorbed than linoleic acid [11]. No study
was so far published on the lymphatic recovery of CLnA.
However, it has already been shown that RA absorption as
TAG did not behave like a common fatty acid because of
its conjugated structure or its trans double bound in ∆11
position or both [13]. In the present study, we also dem-
onstrate that CLnA mixture is preferably incorporated into
neutral lipids similar to RA. The incorporation of trans
fatty acids in NL has long time been demonstrated with
elaidic acid (trans-9 18:1) and shows that it follows the
metabolic pathway of saturated fatty acids [14]. Moreover,
it has been hypothesized by Martin et al. [15] that linoleic
acid, generally in high concentration in diets, may act as a
competitor against RA for its incorporation into phos-
pholipids and for the enzyme needed for the elongation/
desaturation pathway. This hypothesis was also sustained
by Banni et al. [16]. The ∆6 desaturase is the limiting
enzyme for the bioconversion of linoleic acid to arachi-
donic acid [17] and is also needed by n-3 fatty acids in the
elongation/desaturation pathway. CLnA competes as well
for this enzyme as seen by the lower arachidonic acid con-
tent in liver PL in rats fed CLnA. Metabolites from both
Table 3: Fatty acid composition (%) of liver, plasma and adipose tissue of Wistar rats fed RA or CLnA as FFA or TAG. Results are 
expressed as means (SD) of 6 determinations.
Saturated Monounsaturated Polyunsaturated Conjugated
Lipid form Organ Lipid class Diet C16:0 C18:0 16:1 n-7 18:1 n-9 18:2 n-6 20:4 n-6 RA CLnA
Liver PL RA 19.14 23.21 1.19a* 9.25 6.67a*2 3 . 0 8 a 0.23 ND
CLnA 18.65 22.85* 1.91b 9.17* 8.68b 20.20b ND 0.42
NL RA 30.67 3.14 4.46a* 48.41a* 2.66 0.86 1.46 ND
CLnA 31.73 3.33 6.56b 42.63 3.17 0.77 ND 2.18
FFA Plasma PL RA 27.24 25.15 0.79a* 12.24a 14.20 10.25a 0.24 ND
CLnA 27.59 25.73 1.19b 10.93b 15.17 8.79b ND 0.25
TAG RA 25.71 2.13 3.69a* 53.98a* 4.64a 0.30 1.39 ND
CLnA 0.69 1.86 5.90b 46.76b 5.86b 0.30 ND 2.69
CE RA 26.70 0.71 3.15a* 16.83 15.68a 43.73 0.11 ND
CLnA 9.98* 0.66* 4.93b 15.53* 17.53b 41.50 ND 0.32
Adipose TAG RA 22.91 2.35a 6.56* 49.98 6.79 0.26 3.44 ND
CLnA 23.93* 1.95 6.80 47.79 7.16* 0.14 ND 3.79
Liver PL RA 18.68a 22.59a 1.97 8.93a 7.9 21.18 0.29 ND
CLnA 17.20b 24.15b 1.84 7.75 8.1 21.45 ND 0.32
NL RA 33.93 2.89 7.04 42.89 2.58 0.71 1.24 ND
CLnA 34.81 3.04 7.59 40.49 2.54 0.59 ND 1.79
TAG Plasma PL RA 28.51a 24.61a 1.35 11.29a 13.48 9.75 0.26 ND
CLnA 25.95b 26.79b 1.29 10.12b 14.35 10.24 ND 0.27
TAG RA 27.80 1.80 5.97 46.37 5.61 0.34 2.63 ND
CLnA 27.09 1.88 6.60 45.32 5.76 0.34 ND 3.01
CE RA 8.75 0.66 5.01 14.83a 15.34 44.73 0.26 ND
CLnA 8.72 0.55 5.45 12.74 16.77 44.98 ND 0.47
Adipose TAG RA 25.72 2.24a 8.12 46.69 6.05 0.17 3.03 ND
CLnA 26.68 2.00 7.87 45.14 6.30 0.15 ND 3.27
Values with different letters are significantly different (P < 0,05) and compare the fatty acid (RA and CLnA) under the same form (FFA or TAG)
Values with an * are significantly different (P < 0,05) and compare the form (FFA and TAG) within one diet (RA or CLnA)Nutrition & Metabolism 2006, 3:8 http://www.nutritionandmetabolism.com/content/3/1/8
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CLnA isomers were found in NL as in PL. The cis-9,trans-
13,cis-15 18:3 isomer was elongated and desaturated up
to 20:5 n-3 conjugated isomer while cis-9,trans-11,cis-15
18:3 was elongated and desaturated up to 22:6 n-3 conju-
gated isomer. This end product of the elongation/desatu-
ration pathway was obtained without essential fatty acid
deprivation before the experimental period and with a
short term nutritional intake. This shows that the cis-
9,trans-11,cis-15 18:3 can compete for enzyme with essen-
tial fatty acids such as α-linolenic acid to follow the elon-
gation/desaturation pathway. The conjugated isomers of
22:6 n-3 and 22:5 n-3 were found exclusively in polar lip-
ids of liver and plasma while the RA metabolites were
found in neutral lipids as demonstrated by Sebedio et al.
[18]. This shows that conjugated metabolites of cis-
9,trans-11,cis-15 18:3 could interfere in the fatty acid com-
position of membranes which affect their properties such
as fluidity and permeability. Other studies are needed to
confirm this hypothesis.
Conclusion
This study demonstrated that an equimolar mixture of
two CLnA isomers, cis-9,trans-11,cis-15 18:3 and cis-
9,trans-13,cis-15 18:3 has the same apparent absorption
efficiency than RA when ingested under nutritional and
physiological conditions. Both CLnA isomers are mainly
incorporated into neutral lipids. They are metabolized by
the elongation/desaturation pathway similar to α-lino-
lenic acid with the cis-9,trans-11,cis-15 18:3 isomer being
converted into conjugated 22:6 n-3 and with the cis-
9,trans-13,cis-15 18:3 isomer being converted into conju-
gated 20:5 n-3. The biological impact of the ingestion of
these fatty acids has to be considered as they could inter-
fere with lipid metabolism.
Methods
Fatty acids
Free fatty acids of conjugated linoleic acid (CLA) and con-
jugated linolenic acid (CLnA) were gratefully provided by
Naturia Inc. (Sherbrooke, Canada). The high oleic sun-
flower oil and the linseed oil were purchased from Lesieur
(Asnières, France) and Robbe (Compiègne, France),
respectively.
Triacylglycerol (TAG) synthesis
All solvents were purified by distillation before utiliza-
tion. TAG of CLA and CLnA were synthesized as described
by Kodali et al. [19]. TAG were then purified on a silica
column using hexane/diethyl ether (80:20 v/v) as elution
solvent. Thin-layer chromatography on silica gel using
hexane/diethyl ether (80:20 V/V) as elution solvent
showed that the purified fraction consisted entirely of
TAG.
Animals
Six week-old males (n = 24) Wistar rats were purchased
from Elevage Janvier (Le Genest Saint Isle, France). The
initial weight of the animals was 82 ± 7 g. (mean +/- SD).
The rats were individually housed in stainless steel cages
and were placed in an animal house at constant tempera-
ture (22 ± 1°C) and relative humidity (55–60%) with a
12-h light-dark cycle according to French regulation
(authorization A21200 for the animal house and
21CAE056 for one of the author). They were adapted dur-
Table 4: Metabolites of RA and CLnA (%) found in different organs of the Wistar rats fed RA and CLnA as FFA and TAG.
Organ
Plasma Liver Adipose
Dietary form Fatty acids PL TAG PL NL TAG
FFA 20:3 c-11,t-13,c-17 0.058 0.101 0.154 0.136 0.092
20:4 c-8,c-11,t-13,c-17 0.010 0.088 0.039 0.092 0.062
20:5 c-5,c-8,c-11,t-13, c-17 0.013 0.022 0.031 0.019 0.003
*20:5 c-5,c-8,c-11,t-15, c-17 0.009 0.012 0.021 0.010 0.015
22:5 c-7,c-10,c-13,t-15, c-19 0.016 ND 0.049 ND ND
22:6 c-4,c-7,c-10,c-13,t-15,c-19 0.015 ND 0.062 ND ND
TAG 20:3 c-11,t-13,c-17 0.053 0.113 0.136 0.100 0.078
20:4 c-8,c-11,t-13,c-17 0.012 0.104 0.038 0.068 0.056
20:5 c-5,c-8,c-11,t-13, c-17 0.015 0.028 0.028 0.014 0.004
*20:5 c-5,c-8,c-11,t-15, c-17 0.010 0.013 0.022 0.009 0.014
22:5 c-7,c-10,c-13,t-15, c-19 0.017 ND 0.047 ND ND
22:6 c-4,c-7,c-10,c-13,t-15,c-19 0.021 ND 0.068 ND ND
ND, not detected
*Metabolite of c-9,t-13,c-15 18:3 FA, all other metabolite are from c-9,t-11,c-15 18:3
FANutrition & Metabolism 2006, 3:8 http://www.nutritionandmetabolism.com/content/3/1/8
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ing 4 days with a semi-liquid diet (see below) before
being allocated to one of the 4 dietary groups (see below).
Six animals were allocated to each group. The average
starting weight in each group was 101 ± 1 g. At the end of
the 8 days experimental period, the animals were fasted
for 16 hours and weighted. They were then anesthetised
with isofurane and exsanguinated by abdominal aortic
blood puncture. The collected heparinized blood extrac-
tion was centrifuged at 700 g, and +4°C during 10 min.
The plasma was then collected and stored at -20°C until
lipid extraction and analysis. The liver and a sample of the
epididymal adipose tissues were also excised and stored in
a chloroform/methanol (2:1 v/v) solution at -20°C until
lipid extraction.
Diets
The experimental diets were fed in a semi-liquid form in
order to facilitate the determination of food consump-
tion. The diets contained (g/kg) wheat starch: 460,
sucrose: 220, casein: 180, high oleic sunflower/linseed
oils mixture 98:2 w/w: 50, mineral mixture: 50, cellulose:
20, CLA or CLnA: 10, vitamins mix: 10. The diet used for
the adaptation of the rats contained 60 g/kg of a high oleic
sunflower/linseed oil mixture 98:2 w/w instead of 50 g/
kg. CLA and CLnA were studied as FFA and TAG. The fatty
acid content of each diet is summarized in Table 1. Food
was exchanged every two days. At that time, the remaining
semi-liquid food was removed and weighed to determine
food intake. The animals were weighed twice per times a
week. The faeces were collected each day, pooled and fro-
zen at -20°C.
Faeces lipid extraction and analysis
Before being lyophilized, the total faeces collected from
each rat were frozen at -80°C for 24 h. The dried faeces
were cleared of impurities, weighted and crushed with a
ball crusher. A sample of 1 g of the homogenized powder
was used for lipid extraction using a mixture of chloro-
form/methanol/formic acid (2:1:0.02 v/v/v) as a Folch
modified procedure [20,21]. The extract was then evapo-
rated to dryness and left for one night under vacuum in a
dessicator. The total lipid extract was then weighted and
dissolved in chloroform in gauge flask for conservation at
-20°C. The apparent digestion efficiency (ADE) was calcu-
lated as follow [22].
The quantification of each fatty acid in the faeces was
done by GC analysis of their methyl esters using an inter-
nal standard (17:0). Thus, the total fecal lipids were
saponified under mild conditions before methylation.
Briefly, an aliquot of 2 mL of the fecal extract in chloro-
form in gauge flask (around 4 mg/mL) was evaporated
under nitrogen flow and 5 mL of a KOH/ ethanol (95%)
1 M solution was added to the dry extract. The solutions
were left in the dark at room temperature for 16 h. After
addition of 5 mL of acetic acid 1 N and 5 mL of water, the
free fatty acids were extracted with 3 × 5 mL hexane/die-
thyl ether 1:1 v/v. The solution was centrifuged at 700 g
for 3 minutes. The total extract in hexane was then evapo-
rated and methylated using BF3 in methanol (14%) at
room temperature for 20 min. The resulting FAME were
then analysed by GC using a Hewlett-Packard serie II gas
chromatograph equipped with a BPX70 capillary column
(SGE, Melbourne, Australia, 120 m × 0.25 mm i.d×0.25
µm film thickness) with an FID detector and a split less
injector. The oven temperature program was: 60°C for 1
min; 20°C/min up to 170°C for 60 min; 5°C/min up to
210°C for 15 min. FAME were identified using authentic
standards and quantitative data were obtained using the
Diamir software (JMBS Developments, Le Fontanil,
France).
Liver, plasma and adipose tissues lipids
Liver and adipose tissue lipids were extracted using a mix-
ture of chloroform/methanol (2:1 v/v) as described by
Folch et al. [20]. Liver lipids were separated into phos-
pholipids and neutral lipids as described by Juanéda and
Rocquelin [23]. Plasma lipids were extracted according to
Moilanen and Nikkari [24] and separated into PL, CE and
TAG on silica gels plates with hexane/diethyl ether/acetic
acid (80/20/1 V/V/V) as elution solvent. All lipid classes
were methylated with sodium methoxide in methanol
(2N). The resulting FAME were then analysed by gas-liq-
uid chromatography as described above for fecal fatty
acids. FAME were identified using authentic standards. RA
metabolites were identified as described by Sébédio et al.
[18] and CLnAs metabolites were identified as described
by Destaillats et al. [8]. Qualitative data were obtained
using the Diamir software (JMBS Developments, Le Fon-
tanil, France).
Statistical analysis
Data are presented as mean ± SD and comparison were
done by using SAS software as a one way FA (CLA or
CLnA) or lipid form (FFA or TAG) ANOVA procedure. P
values of less than 0.05 were considered as significant.
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